2-231000380-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_139073.5(SPATA3):c.316G>A(p.Ala106Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,515,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139073.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA3 | NM_139073.5 | c.316G>A | p.Ala106Thr | missense_variant | 2/5 | ENST00000433428.7 | NP_620712.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA3 | ENST00000433428.7 | c.316G>A | p.Ala106Thr | missense_variant | 2/5 | 1 | NM_139073.5 | ENSP00000403804 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152122Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000448 AC: 61AN: 136126Hom.: 0 AF XY: 0.000404 AC XY: 29AN XY: 71816
GnomAD4 exome AF: 0.000180 AC: 246AN: 1362966Hom.: 0 Cov.: 36 AF XY: 0.000169 AC XY: 113AN XY: 668230
GnomAD4 genome AF: 0.000197 AC: 30AN: 152122Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2022 | The c.316G>A (p.A106T) alteration is located in exon 2 (coding exon 2) of the SPATA3 gene. This alteration results from a G to A substitution at nucleotide position 316, causing the alanine (A) at amino acid position 106 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at